APA引文

Zhong, E., & Huang, H. (2016). Crizotinib in ROS1 rearranged non-small cell lung cancer (NSCLC), from response to resistance. BMJ Case Rep.

Citação norma Chicago

Zhong, Eric, and Hua Huang. "Crizotinib in ROS1 Rearranged Non-small Cell Lung Cancer (NSCLC), From Response to Resistance." BMJ Case Rep 2016.

MLA引文

Zhong, Eric, and Hua Huang. "Crizotinib in ROS1 Rearranged Non-small Cell Lung Cancer (NSCLC), From Response to Resistance." BMJ Case Rep 2016.

警告：這些引文格式不一定是100％准確.